| Log in

EILSF makes first close of new healthcare fund, scores third exit this year with Gland Pharma

28 November, 2013

Life sciences-focused private equity fund EILSF (Evolvence India Life Sciences Fund), which has just struck a deal with buyout giant KKR & Co to sell its stake in Gland Pharma ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
India Life Sciences Fund II backs dermatology chain Oliva

India Life Sciences Fund II backs dermatology chain Oliva

Madhav A Chanchani 4 years ago
Good looks matter to the Indian consumer, and private equity investors know it...
Evolvence Life Sciences Fund Backs Vivimed Buy With $12.5M Financing

Evolvence Life Sciences Fund Backs Vivimed Buy With $12.5M Financing

Madhav A Chanchani 6 years ago
Sector-focused private equity fund Evolvence India Life Sciences Fund has backed...
India Life Sciences Fund II raises $143M, to deploy $40M in 12 months

India Life Sciences Fund II raises $143M, to deploy $40M in 12 months

Shruti Ambavat 3 years ago
Life sciences-focused private equity fund manager InvAscent has raised Rs 875...
No Comments

EILSF makes first close of new healthcare fund, scores third exit this year with Gland Pharma

Powered by WordPress.com VIP